Antibodies against Claspin and Timeless have been successfully used on paraffin-embedded tumor samples25,26, which was confirmed here for Timeless with breast cancer samples (Supplementary Fig. 1a, b). This evidence concerns the gene CLSPN and breast carcinoma.